
zzso drugs are available in the United States for the treatment of zzso multiple sclerosis zzso including zzso zzso zzso zzso and zzso zzso Another zzso of zzso is available in Europe, Canada, and other zzso zzso is also indicated for the treatment of worsening forms of zzso and secondary progressive zzso zzso In addition to reductions in annual zzso rates and other measures of clinical zzso the zzso drugs appear to reduce zzso measures of disease zzso Available data suggest that the efficacy of zzso therapy is sustained for at least for 4 to 6 zzso zzso of clinical drug trials have been used as a rationale to support treatment of early zzso with a zzso zzso Other medical therapies are used in the management of zzso including treatments to help manage zzso symptoms such as zzso and zzso dysfunction, and zzso to zzso recovery from acute zzso In some situations, interventions are used to minimize side effects of zzso drug zzso Several currently marketed treatments, including IV zzso methotrexate, and zzso are being evaluated as treatments for zzso in combination with the approved zzso zzso compounds, including oral zzso of zzso zzso and zzso are in various stages of zzso 

